Stockreport

Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates [Yahoo! Finance]

Century Therapeutics, Inc.  (IPSC) 
PDF New Drug (IND)-enabling studies; IND submission expected in 4Q 2026 to support anticipated initial clinical data in 2H 2027 CNTY-308, a CD19-targeted CAR-iT cell thera [Read more]